• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本努南综合征患者的生长参考标准。

Growth references for Japanese individuals with Noonan syndrome.

作者信息

Isojima Tsuyoshi, Sakazume Satoru, Hasegawa Tomonobu, Ogata Tsutomu, Nakanishi Toshio, Nagai Toshiro, Yokoya Susumu

机构信息

Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Department of Pediatrics, Dokkyo Medical University Koshigaya Hospital, Koshigaya, Japan.

出版信息

Pediatr Res. 2016 Apr;79(4):543-8. doi: 10.1038/pr.2015.254. Epub 2015 Dec 9.

DOI:10.1038/pr.2015.254
PMID:26650342
Abstract

BACKGROUND

Noonan syndrome (NS) is a clinically and genetically heterogeneous syndrome characterized by distinctive facial features, short stature, congenital heart diseases, and other comorbidities. NS-specific growth charts are essential for NS care, but currently no such charts are available for Asian populations.

METHODS

We conducted a nationwide survey by collaborating with three academic societies in Japan. We obtained the data of 356 clinically diagnosed NS subjects from 20 hospitals. The Lambda-Mu-Sigma method was used for establishing growth charts.

RESULTS

A total of 308 subjects (males: 159 and females: 149) were analyzed after excluding 48 subjects because of missing auxological data (26 subjects), presence of complications affecting growth (5 subjects), and extreme longitudinal growth aberrations which lay more than three standard deviation scores from the mean in this population (17 subjects). Genetic analyses were performed in 150 patients (48.7%); 103 (68.7%) were reported to have some abnormalities in the known causative genes. Cardiovascular diseases were found in 256 patients (83.1%). The NS-specific height, weight, and BMI charts were constructed with 3,249 mixed longitudinal and cross-sectional measurements.

CONCLUSION

Growth standards for Japanese individuals with NS were established. These charts are expected to be used in various clinical settings.

摘要

背景

努南综合征(NS)是一种临床和遗传异质性综合征,其特征为独特的面部特征、身材矮小、先天性心脏病及其他合并症。NS特异性生长图表对NS的治疗至关重要,但目前亚洲人群尚无此类图表。

方法

我们与日本的三个学术团体合作开展了一项全国性调查。我们从20家医院获取了356例临床诊断为NS的受试者的数据。采用Lambda-Mu-Sigma方法建立生长图表。

结果

排除48例受试者后,共对308例受试者(男性159例,女性149例)进行了分析,排除原因包括缺乏体格学数据(26例)、存在影响生长的并发症(5例)以及纵向生长异常极端,偏离该人群均值超过三个标准差分数(17例)。对150例患者(48.7%)进行了基因分析;其中103例(68.7%)报告在已知致病基因中有某些异常。256例患者(83.1%)发现患有心血管疾病。利用3249次混合纵向和横断面测量构建了NS特异性身高、体重和BMI图表。

结论

建立了日本NS患者的生长标准。这些图表有望用于各种临床环境。

相似文献

1
Growth references for Japanese individuals with Noonan syndrome.日本努南综合征患者的生长参考标准。
Pediatr Res. 2016 Apr;79(4):543-8. doi: 10.1038/pr.2015.254. Epub 2015 Dec 9.
2
Growth standards of patients with Noonan and Noonan-like syndromes with mutations in the RAS/MAPK pathway.RAS/MAPK 通路突变的 Noonan 及 Noonan 样综合征患者的生长标准。
Am J Med Genet A. 2012 Nov;158A(11):2700-6. doi: 10.1002/ajmg.a.35519. Epub 2012 Aug 6.
3
Validation of auxological reference values for Japanese children with Noonan syndrome and comparison with growth in children with Turner syndrome.日本努南综合征患儿生长学参考值的验证及与特纳综合征患儿生长情况的比较。
Clin Pediatr Endocrinol. 2017;26(3):153-164. doi: 10.1297/cpe.26.153. Epub 2017 Jul 27.
4
Noonan syndrome: clinical features, diagnosis, and management guidelines.努南综合征:临床特征、诊断和管理指南。
Pediatrics. 2010 Oct;126(4):746-59. doi: 10.1542/peds.2009-3207. Epub 2010 Sep 27.
5
A PTPN11 gene mutation (Y63C) causing Noonan syndrome is not associated with short stature in general population.一种导致努南综合征的PTPN11基因突变(Y63C)在普通人群中与身材矮小无关。
Tohoku J Exp Med. 2006 Mar;208(3):255-9. doi: 10.1620/tjem.208.255.
6
The Growth Characteristics of Patients with Noonan Syndrome: Results of Three Years of Growth Hormone Treatment: A Nationwide Multicenter Study.努南综合征患者的生长特征:三年生长激素治疗结果:一项全国性多中心研究
J Clin Res Pediatr Endocrinol. 2016 Sep 1;8(3):305-12. doi: 10.4274/jcrpe.3013. Epub 2016 Apr 29.
7
[Noonan syndrome: genetic and clinical update and treatment options].[努南综合征:遗传学与临床进展及治疗选择]
An Pediatr (Engl Ed). 2020 Jul;93(1):61.e1-61.e14. doi: 10.1016/j.anpedi.2020.04.008. Epub 2020 May 31.
8
Growth response, near-adult height, and patterns of growth and puberty in patients with noonan syndrome treated with growth hormone.生长激素治疗努南综合征患者的生长反应、接近成人身高以及生长和青春期模式
J Clin Endocrinol Metab. 2009 Jul;94(7):2338-44. doi: 10.1210/jc.2008-2094. Epub 2009 Apr 28.
9
Noonan syndrome in diverse populations.不同人群中的努南综合征。
Am J Med Genet A. 2017 Sep;173(9):2323-2334. doi: 10.1002/ajmg.a.38362. Epub 2017 Jul 27.
10
Adult height in Noonan syndrome.努南综合征患者的成人身高
Am J Med Genet A. 2003 Nov 15;123A(1):68-71. doi: 10.1002/ajmg.a.20502.

引用本文的文献

1
Childhood BMI trajectories and sociodemographic factors in an Italian pediatric population.意大利儿科人群的儿童期体重指数轨迹与社会人口学因素
Sci Rep. 2025 Jan 28;15(1):3525. doi: 10.1038/s41598-025-87997-3.
2
Genetic backgrounds and genotype-phenotype relationships in anthropometric parameters of 116 Japanese individuals with Noonan syndrome.116名努南综合征日本个体人体测量参数的遗传背景及基因型-表型关系
Clin Pediatr Endocrinol. 2024;33(2):50-58. doi: 10.1297/cpe.2024-0005. Epub 2024 Feb 26.
3
An anthropometric evidence against the use of age-based estimation of bodyweight in pediatric patients admitted to intensive care units.

本文引用的文献

1
Cardiovascular disease in Noonan syndrome.努南综合征相关心血管疾病
Arch Dis Child. 2014 Jul;99(7):629-34. doi: 10.1136/archdischild-2013-305047. Epub 2014 Feb 17.
2
Proposal of new auxological standards for Japanese girls with turner syndrome.针对日本特纳综合征女孩的新体格学标准提案。
Clin Pediatr Endocrinol. 2010 Jul;19(3):69-82. doi: 10.1297/cpe.19.69. Epub 2010 Aug 31.
3
Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome.RIT1 中的功能获得性突变导致努南综合征,一种 RAS/MAPK 通路综合征。
一项人体测量学证据反对在重症监护病房收治的儿科患者中使用基于年龄的体重估计。
Sci Rep. 2023 Mar 2;13(1):3574. doi: 10.1038/s41598-023-30566-3.
4
Growth in girls with Turner syndrome.特纳综合征女孩的生长情况。
Front Endocrinol (Lausanne). 2023 Jan 12;13:1068128. doi: 10.3389/fendo.2022.1068128. eCollection 2022.
5
Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status.生长激素治疗努南综合征患儿的结局:PTPN11突变状态的影响
Endocr Connect. 2022 Apr 15;11(4):e210615. doi: 10.1530/EC-21-0615.
6
Establishment of a longitudinal growth chart corresponding to pubertal timing.建立与青春期发育时间相对应的纵向生长图表。
Clin Pediatr Endocrinol. 2018;27(4):215-224. doi: 10.1297/cpe.27.215. Epub 2018 Oct 30.
7
Development of disease-specific growth charts in Turner syndrome and Noonan syndrome.特纳综合征和努南综合征中疾病特异性生长曲线的制定。
Ann Pediatr Endocrinol Metab. 2017 Dec;22(4):240-246. doi: 10.6065/apem.2017.22.4.240. Epub 2017 Dec 31.
8
Validation of auxological reference values for Japanese children with Noonan syndrome and comparison with growth in children with Turner syndrome.日本努南综合征患儿生长学参考值的验证及与特纳综合征患儿生长情况的比较。
Clin Pediatr Endocrinol. 2017;26(3):153-164. doi: 10.1297/cpe.26.153. Epub 2017 Jul 27.
9
Noonan syndrome in diverse populations.不同人群中的努南综合征。
Am J Med Genet A. 2017 Sep;173(9):2323-2334. doi: 10.1002/ajmg.a.38362. Epub 2017 Jul 27.
Am J Hum Genet. 2013 Jul 11;93(1):173-80. doi: 10.1016/j.ajhg.2013.05.021. Epub 2013 Jun 20.
4
Noonan syndrome.努南综合征。
Lancet. 2013 Jan 26;381(9863):333-42. doi: 10.1016/S0140-6736(12)61023-X. Epub 2013 Jan 10.
5
Growth standards of patients with Noonan and Noonan-like syndromes with mutations in the RAS/MAPK pathway.RAS/MAPK 通路突变的 Noonan 及 Noonan 样综合征患者的生长标准。
Am J Med Genet A. 2012 Nov;158A(11):2700-6. doi: 10.1002/ajmg.a.35519. Epub 2012 Aug 6.
6
Health and quality of life in adults with Noonan syndrome.努南综合征成人的健康和生活质量。
J Pediatr. 2012 Sep;161(3):501-505.e1. doi: 10.1016/j.jpeds.2012.02.043. Epub 2012 Apr 10.
7
Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms.RAS-MAPK 信号通路失调导致的疾病:表型谱和分子机制。
Ann N Y Acad Sci. 2010 Dec;1214:99-121. doi: 10.1111/j.1749-6632.2010.05790.x. Epub 2010 Oct 19.
8
Noonan syndrome: clinical features, diagnosis, and management guidelines.努南综合征:临床特征、诊断和管理指南。
Pediatrics. 2010 Oct;126(4):746-59. doi: 10.1542/peds.2009-3207. Epub 2010 Sep 27.
9
Noonan syndrome: clinical aspects and molecular pathogenesis.努南综合征:临床特征与分子发病机制
Mol Syndromol. 2010 Feb;1(1):2-26. doi: 10.1159/000276766. Epub 2010 Jan 15.
10
Growth in Noonan syndrome.努南综合征的生长情况。
Horm Res. 2009 Dec;72 Suppl 2:31-5. doi: 10.1159/000243776. Epub 2009 Dec 22.